Close
Digital Health & Ai Innovation summit 2026
APE 2026

Hologic to Webcast Presentations at Upcoming Investor Conferences

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Novartis Plans its Fourth US Radioligand...

Novartis, which is a world-leading innovative medicines company, has...

Tempus-NYU Langone Collaboration Advances Precision Oncology

Tempus and NYU Langone Health have signed a multi-year...

Boston Scientific Valencia Acquisition Expands Portfolio

Boston Scientific has entered into an agreement to acquire...

Hologic, Inc. announced that the Company will present at these upcoming investor conferences:

The Deutsche Bank 43rd Annual Health Care Conference in Boston, MA on Wednesday, May 9 at 8:40 a.m. Eastern Time (ET).

The Goldman Sachs Third Annual Leveraged Finance Conference in Rancho Palos Verdes, CA on Thursday, May 10 at 11:20 a.m. Pacific Time (PT)

The Bank of America Merrill Lynch 2018 Healthcare Conference in Las Vegas, NV on Tuesday, May 15 at 3 p.m. PT

Each presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investors.hologic.com. The webcasts will be available for 30 days following the events.

About Hologic
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com

Latest stories

Related stories

Novartis Plans its Fourth US Radioligand Therapy Facility

Novartis, which is a world-leading innovative medicines company, has...

Tempus-NYU Langone Collaboration Advances Precision Oncology

Tempus and NYU Langone Health have signed a multi-year...

Boston Scientific Valencia Acquisition Expands Portfolio

Boston Scientific has entered into an agreement to acquire...

Haemonetics Vivasure Acquisition Reaches Valuation of €185M

Haemonetics has agreed to acquire Vivasure Medical for up...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »